Financial Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences Share by Ken Dropiewski on January 22, 2019 More in Financial: Pulse Biosciences Reports Business Updates and Fourth Quarter and Full Year 2025 Financial Results February 19, 2026 Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth February 19, 2026 Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences February 19, 2026 Share this story Facebook Twitter LinkedIn